Literature DB >> 15581755

Bilateral pulmonary infiltrates in a patient with ulcerative colitis receiving mesalazine.

Prabath W B Nanayakkara1, Evelien de Jong, Piet E Postmus.   

Abstract

A 36-year-old woman presented with a 2-month history of dry cough, bilateral pain in the upper chest, and low-grade fever. She had a 1-year history of ulcerative colitis (UC), which was treated with mesalazine. Cultures of sputum and bronchoalveolar lavage (BAL) fluid were negative. Chest radiograph and a computed tomography (CT) scan showed dense bilateral subpleural infiltrates in both upper lobes. A c-ANCA test was positive in a 1:1280 titer, and further specification showed antibodies against proteinase-3 antigen. Due to the possibility of mesalazine toxicity, this medication was stopped. Within 2 weeks, the patient's symptoms markedly improved, together with the chest roentgenogram.

Entities:  

Year:  2004        PMID: 15581755     DOI: 10.1016/j.ejim.2004.08.007

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  3 in total

1.  Severe airflow obstruction in a patient with ulcerative colitis and toxic epidermal necrolysis: A case report.

Authors:  Shijima Taguchi; Junichi Furuta; Gen Ohara; Katsunori Kagohashi; Hiroaki Satoh
Journal:  Exp Ther Med       Date:  2015-02-24       Impact factor: 2.447

2.  Mesalazine-induced multi-organ hypersensitivity.

Authors:  Bruno Sposato; Maria Pia Allegri; Maria Piera Riccardi; Silvia Chigiotti; Cesira Nencioni; Barbara Ricciardi; Tiziana Carli; Alberto Cresti; Maria Grazia Perari; Maria Giovanna Migliorini; Mario Toti
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

3.  ANCA-Associated Vasculitis in Inflammatory Bowel Disease.

Authors:  Jocelyn X Jiang; Karuna Keat; Sanjay Swaminathan
Journal:  Dig Dis Sci       Date:  2019-05-15       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.